for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Celsion Corporation

CLSN.OQ

Latest Trade

1.24USD

Change

-0.08(-6.06%)

Volume

758,268

Today's Range

1.24

 - 

1.31

52 Week Range

0.44

 - 

5.26

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Celsion Reports Net Loss For Q1 Of $5.7 Million

May 14 (Reuters) - Celsion Corp <CLSN.O>::CELSION CORPORATION REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.CELSION - REPORTED A NET LOSS FOR Q1 OF 2021 OF $5.7 MILLION ($0.09 PER SHARE) COMPARED WITH A NET LOSS OF $5.1 MILLION ($0.20 PER SHARE) FOR YEAR-AGO QUARTER.

Celsion Corporation Receives FDA Fast Track Designation For Gen-1 In Advanced Ovarian Cancer

Feb 22 (Reuters) - Celsion Corp <CLSN.O>::CELSION CORPORATION RECEIVES FDA FAST TRACK DESIGNATION FOR GEN-1 IN ADVANCED OVARIAN CANCER.

Celsion Corp - On Jan 27, 2021, Co Received A Notice From Nasdaq Listing Qualifications Department

Jan 29 (Reuters) - Celsion Corp <CLSN.O>::CELSION CORP - ON JAN 27, 2021, CO RECEIVED A NOTICE FROM NASDAQ LISTING QUALIFICATIONS DEPARTMENT.CELSION CORP -DUE TO DR. ALBERTO MARTINEZ’S RESIGNATION ON DEC 31, 2020, CO IS NO LONGER IN COMPLIANCE WITH NASDAQ’S AUDIT COMMITTEE REQUIREMENT.CELSION - DR. DONALD BRAUN, HAS AGREED TO SERVE ON AUDIT COMMITTEE TO FILL VACANCY, HIS APPOINTMENT WILL SATISFY NASDAQ'S AUDIT COMMITTEE REQUIREMENT.

Altium Capital Management Lp Reports Passive Stake Of 8.9% In Celsion Corp As Of Jan. 22 - SEC Filing

Jan 29 (Reuters) - Altium Capital Management::ALTIUM CAPITAL MANAGEMENT LP REPORTS PASSIVE STAKE OF 8.9% IN CELSION CORP AS OF JAN. 22 - SEC FILING.

Celsion Files Provisional U.S. Patent Application For Broad Range Of DNA Vaccines

Jan 28 (Reuters) - Celsion Corp <CLSN.O>::CELSION CORPORATION FILES PROVISIONAL U.S. PATENT APPLICATION FOR A BROAD RANGE OF NEXT GENERATION DNA VACCINES.

Celsion Corp Says Delivered Notice To Lincoln Park Capital Terminating Purchase Agreement With Lincoln Park Capital

Jan 21 (Reuters) - Celsion Corp <CLSN.O>::CELSION CORP - DELIVERED NOTICE TO LINCOLN PARK CAPITAL TERMINATING PURCHASE AGREEMENT, DATED SEPT 8, 2020 WITH LINCOLN PARK CAPITAL EFFECTIVE JAN 21.CELSION CORP - FROM SEPT 8, 2020 THROUGH TERMINATION DATE, SOLD 2.8 MILLION COMMON SHARES UNDER 2020 PURCHASE AGREEMENT GENERATING PROCEEDS OF $2.2 MILLION.CELSION CORP - CO HAS NO FURTHER OBLIGATIONS UNDER 2020 PURCHASE AGREEMENT.

Celsion Corporation Reports Q3 Loss Per Share $0.24

Nov 16 (Reuters) - Celsion Corp <CLSN.O>::ORATION REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q3 LOSS PER SHARE $0.24.Q3 EARNINGS PER SHARE ESTIMATE $-0.13 -- REFINITIV IBES DATA.

Celsion Says Since April 27, A Total Of 14 New Deaths Have Been Reported In Optima Study

Oct 12 (Reuters) - Celsion Corp <CLSN.O>::CELSION CORP - SINCE APRIL 27, A TOTAL OF 14 NEW DEATHS HAVE BEEN REPORTED IN OPTIMA STUDY FIVE OF WHICH OCCURRED SINCE JULY.CELSION CORP - NOW HAVE A TOTAL OF 174 DEATHS IN OPTIMA STUDY FROM A TOTAL PATIENT ENROLLMENT OF 556.CELSION CORP - OPTIMA STUDY'S STATISTICAL PLAN SPECIFIES A MINIMUM OF 197 DEATHS FOR FINAL DATA ANALYSIS.CELSION - IN PRELIMINARY EVALUATION OF TOPLINE DATA, CO DETERMINED SHOULD CONTINUE TO FOLLOW PATIENTS UNTIL FUTILITY IS EITHER CONFIRMED OR DISPELLED.CELSION CORP - HAS SUBMITTED ALL OPTIMA STUDY CLINICAL TRIAL DATA TO NATIONAL INSTITUTES OF HEALTH.CELSION CORP - NOTED A TIMED-BASED CHANGE IN DEATHS IN THERMODOX TREATMENT ARM SUGGESTED A PROPORTIONALITY ISSUE THAT REQUIRED FURTHER EVALUATION.CELSION CORP - FIRMLY BELIEVE, THAT CO IS OBLIGATED TO UNDERTAKE RIGOROUS EVALUATION OF DATA WHILE CO CONTINUES TO FOLLOW PATIENTS.CELSION CORP - CONTINUE TO ENROLL PATIENTS IN PHASE II PORTION OF OVATION 2 STUDY EVALUATING GEN-1 FOR TREATMENT OF ADVANCED OVARIAN CANCER.CELSION CORP - EXPECT PATIENT ENROLLMENT IN OVATION 2 STUDY TO BE COMPLETED BY END OF Q2 OF 2021.

Celsion Files For Resale By Selling Stockholders Of Up To 247,524 Shares

Oct 9 (Reuters) - Celsion Corp <CLSN.O>::CELSION CORP - FILES FOR RESALE BY SELLING STOCKHOLDERS OF UP TO 247,524 SHARES - SEC FILING.

Celsion Announces Common Stock Purchase Agreement With Lincoln Park Capital

Sept 8 (Reuters) - Celsion Corp <CLSN.O>::CELSION ANNOUNCES COMMON STOCK PURCHASE AGREEMENT WITH LINCOLN PARK CAPITAL AND PROVIDES UPDATES ON OVATION 2 STUDY.CELSION CORP - ENTERED INTO COMMON STOCK PURCHASE AGREEMENT FOR ISSUANCE AND SALE, FROM TIME TO TIME, OF UP TO $26 MILLION OF SHARES OF COMMON STOCK.CELSION CORP - LPC MADE AN INITIAL PURCHASE OF $1 MILLION OF COMMON STOCK AT $1.00 PER SHARE.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up